Table 3

Number of events (n), PYR and incidence rates (N/1000 PYR) of death in 17 512 patients with new-onset RA identified between 1997 and 2015 and in an individually matched general population comparator cohort (n=78 847). HR (RR) and 95% CI with the matching factors taken into account and adjusted for age and educational level. Overall and by sex, rheumatoid factor status, DAS28 at diagnosis, age at diagnosis and calendar period of diagnosis

Patients with new-onset RAGeneral population comparator subjectsHR (95% CI)
nPYRIncidence ratenPYRIncidence rate
Overall2386123 36019.3 (17.3 to 21.4)9850549 76917.9 (17.0 to 18.9)1.01 (0.96 to 1.06)
Women141286 16216.4 (14.1 to 18.7)5607381 57414.7 (13.7 to 15.7)1.06 (1.00 to 1.13)
Men97437 19726.2 (21.9 to 30.4)4243168 19425.2 (23.3 to 27.2)0.93 (0.86 to 1.00)
Seropositive RA158581 45519.5 (16.9 to 22.0)9850549 76917.9 (17.0 to 18.9)1.20 (1.13 to 1.28)
Seronegative RA80141 90419.1 (15.7 to 22.5)9850549 76917.9 (17.0 to 18.9)0.75 (0.70 to 0.82)
DAS28≤3.2 at diagnosis16211 77713.8 (8.7 to 18.9)9850549 76917.9 (17.0 to 18.9)0.77 (0.64 to 0.92)
DAS28>3.2 at diagnosis1981100 72319.7 (17.3 to 22.0)9850549 76917.9 (17.0 to 18.9)1.02 (0.97 to 1.07)
Age at diagnosis (years)
 <5310444 0102.4 (1.1 to 3.6)397201 2052.0 (1.4 to 2.5)1.15 (0.92 to 1.44)
 53 to <6335534 02810.4 (7.4 to 13.5)1306152 1828.6 (7.3 to 9.9)1.20 (1.06 to 1.35)
 63 to <7266325 62225.9 (20.9 to 30.8)2418113 35821.3 (19.2 to 23.5)1.20 (1.10 to 1.32)
 ≥72126419 69764.2 (55.8 to 72.5)572983 02269.0 (64.9 to 73.1)0.86 (0.80 to 0.92)
Calendar period
 1997–200192438 55324.0 (18.2 to 29.7)3613172 74620.9 (18.4 to 23.5)1.09 (1.01 to 1.18)
 2002–200681540 84920.0 (15.6 to 24.4)3242180 75417.9 (16.0 to 19.9)1.02 (0.94 to 1.10)
 2007–201153533 58015.9 (12.6 to 19.3)2372149 71915.8 (14.3 to 17.4)0.95 (0.86 to 1.05)
 2012–201511210 37510.8 (8.0 to 13.6)62346 54913.4 (11.9 to 14.9)0.77 (0.63 to 0.95)
  • DAS28, Disease Activity Score 28-joint counts; PYR, person-years at risk; RA, rheumatoid arthritis; RR, relative risk.